Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Mar;339(3):306-11.
doi: 10.1007/BF00173583.

GABA-mediated modification of despair behavior in mice

Affiliations

GABA-mediated modification of despair behavior in mice

K O Aley et al. Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar.

Abstract

Gamma-aminobutyric acid (GABA) and GABA agonists exhibited biphasic response on forced swimming-induced despair behavior in mice; smaller doses, GABA (100 mg/kg), muscimol (0.05 and 0.1 mg/kg), baclofen (0.5 and 1 mg/kg), sodium valproate (100 mg/kg), piracetam (25 mg/kg), and fengabine (10 and 20 mg/kg) decreasing forced swimming-induced immobility period, while higher doses enhancing the immobility period. GABA, muscimol, and baclofen also reversed reserpine-induced prolongation of the forced swimming-induced immobility. When GABA was administered with antidepressant agents, it potentiated the effect of some classical antidepressants. Bicuculline and picrotoxin, the GABAergic antagonists, by themselves enhanced the forced swimming-induced immobility period, but they had no significant effect on reserpine-induced prolongation of the immobility period. When animals were chronically exposed to forced swimming, there was a gradual increase of the immobility period which was reduced on treatment with GABAergic agents. It is suggested that GABA has a modulatory role in reversing forced swimming-induced despair and also in potentiating the effect of antidepressants.

PubMed Disclaimer

References

    1. Neuropharmacology. 1985 Mar;24(3):217-22 - PubMed
    1. Am J Psychiatry. 1980 Mar;137(3):362-4 - PubMed
    1. J Pharmacol Exp Ther. 1985 Oct;235(1):191-9 - PubMed
    1. Am J Psychiatry. 1965 Nov;122(5):509-22 - PubMed
    1. J Neurochem. 1984 Mar;42(3):652-7 - PubMed